597 filings
Page 5 of 30
8-K
uoiltl qvqi1qka9u5vl
23 Jun 22
Timber Pharmaceuticals Announces First Patients Enrolled in Phase 3 ASCEND Clinical Trial Evaluating TMB-001 in Congenital Ichthyosis
8:15am
8-K
dwz83048
10 Jun 22
Regulation FD Disclosure
4:05pm
8-K
cvp80358gemv
7 Jun 22
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
h9y9ty
31 May 22
Timber Pharmaceuticals Receives FDA Breakthrough Therapy Designation for TMB-001 for the Treatment of Congenital Ichthyosis
8:18am
8-K
lx0y1gw0jfekc
12 May 22
Timber Pharmaceuticals Provides Business Update and Announces First Quarter 2022 Financial Results
4:32pm
8-K
xi732w8 6k6ies
28 Apr 22
Timber Pharmaceuticals Announces Fast Track Designation Granted by FDA for TMB-001 in Severe Subtypes of Congenital Ichthyosis
8:20am
8-K
382a1ygjz smn5bvcfy
25 Apr 22
Other Events
5:16pm
DEFA14A
ntvryxoant6xeq07q
22 Apr 22
Additional proxy soliciting materials
4:54pm
4
ahymxpidnkm0n
19 Apr 22
Timber Pharmaceuticals / Joseph Lucchese ownership change
1:03pm
4
y7vlp
19 Apr 22
Timber Pharmaceuticals / Alan Mendelsohn ownership change
1:02pm
4
8u7s0v
19 Apr 22
Timber Pharmaceuticals / John Koconis ownership change
1:01pm
4
ycd999ebj9
19 Apr 22
Timber Pharmaceuticals / David E Cohen ownership change
12:59pm
4
c6b8yn
19 Apr 22
Timber Pharmaceuticals / Edward J Sitar ownership change
12:58pm
4
f7ep9pj5t9kr3q wb5
19 Apr 22
Timber Pharmaceuticals / Gianluca Pirozzi ownership change
12:57pm
4
kass3ixa1xyada3
19 Apr 22
Timber Pharmaceuticals / Lubor Gaal ownership change
12:54pm
4
m9jd4768 i6
15 Apr 22
Timber Pharmaceuticals / Zachary Rome ownership change
4:10pm
8-K
xendxwh6ykuh
11 Apr 22
Amendments to Articles of Incorporation or Bylaws
4:20pm